Studies treatments and survival in adults with intermediate-stage liver cancer
Observes how adults with intermediate-stage liver cancer are treated and how long they survive.
Plain-language title generated from the registry record
Registry title: Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma.
Key facts
- Where
- Sohag, EgyptSee the site
Where in Egypt
- Sohag Oncology CenterSohag, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sohag University
- Trial code
- NCT07449637
- Record updated
- 4 March 2026
- Original description
The goal of this observational study is to learn about the different treatment options for intermediate-stage hepatocellular carcinoma. The main question it aims to answer is:Read full original descriptionShow less
Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma: An Observational Cohort Study.
The goal of this observational study is to learn about the different treatment options for intermediate-stage hepatocellular carcinoma. The main question it aims to answer is:
- What are the survival outcomes among participants aged 18 or older who receive treatment for intermediate-stage hepatocellular carcinoma?
Inclusion: Aged ≥18 years; Both sexes; Diagnosis of hepatocellular carcinoma based on accepted radiologic or histologic criteria; Classified as intermediate stage (BCLC-B) at time of decision for first-line treatment; Child-Pugh A or B; ECOG performance status 0-1.
Exclusion: Prior curative therapy (resection, transplantation, curative ablation); BCLC A, C, or D at diagnosis; Missing essential data (imaging, liver function, treatment records); Mixed HCC-cholangiocarcinoma.